IPOPLUS
markets14 Jul 2026, 5:45 am

After Muted H1, D-Street Gears Up for ₹33,000-Crore IPO Rush: Manipal Health, Zepto, Cube Highways Lead the Pipeline

By IPO Plus

After a muted H1 2026, D-Street readies a ₹33,000-crore IPO rush led by Manipal Health, Zepto, and Cube Highways—here's what investors should know now.

After Muted H1, D-Street Gears Up for ₹33,000-Crore IPO Rush: Manipal Health, Zepto, Cube Highways Lead the Pipeline

After Muted H1, D-Street Gears Up for ₹33,000-Crore IPO Rush: Manipal Health, Zepto, Cube Highways Lead the Pipeline

Key Takeaways

  • India's IPO market saw a subdued H1 2026 due to global volatility, cautious FII flows, and thin grey-market premiums.
  • D-Street is preparing for a ₹33,000-crore IPO rush in H2 2026, led by Manipal Health, Zepto, and Cube Highways.
  • Manipal Health's offering is expected to be one of the largest hospital-sector listings, backed by a strong multi-specialty network.
  • Zepto represents a high-growth consumer-tech bet, while Cube Highways offers a defensive, cash-flow-driven infrastructure play.
  • Tracking live subscription data, GMP trends, and allotment status through platforms like IPO Plus can help investors navigate the upcoming IPO wave.

Why Did India's IPO Market Stay Muted in H1 2026?

What Factors Slowed Mainboard Listings in the First Half?

India's primary market moved at a noticeably slower pace through the first half of 2026, with fewer big-ticket mainboard debuts and thinner investor enthusiasm compared to previous cycles. Deal flow that usually builds momentum quarter after quarter instead stayed patchy, leaving merchant bankers and promoters waiting for a better window to price their offers.

A mix of global and domestic headwinds kept issuers on the sidelines during the opening months of the year. Elevated volatility in benchmark indices, uncertainty around interest rate direction, and cautious foreign institutional flows made companies wary of testing the primary market. Several firms that had filed draft papers chose to wait rather than launch into a choppy secondary market, fearing weak listing-day pops or, worse, listings below their issue price.

How Did Grey-Market Sentiment Reflect Investor Caution?

Grey-market premium data through H1 2026 painted a clear picture of subdued risk appetite. Unofficial premiums on several upcoming issues stayed thin or even turned negative in the days before listing, a sign that traders were pricing in limited near-term upside. Compared to the aggressive premiums seen during hotter IPO cycles, the muted GMP trend signalled that investors were prioritising fundamentals and fair valuation over speculative listing gains.

Not every sector felt the slowdown equally. Smaller manufacturing issuers, a handful of NBFC-linked offerings, and some richly valued new-age technology names struggled to draw sustained demand, with retail and non-institutional categories often just about scraping through subscription targets. In contrast, healthcare, select infrastructure-linked plays, and financial services names with strong balance sheets managed relatively steadier interest, hinting at where demand would likely concentrate once sentiment turned positive again.

Sector-Wise Snapshot: Which Segments Underperformed

What Is Driving the ₹33,000-Crore IPO Rush in H2 2026?

How Much Capital Is Set to Hit D-Street This Half?

Dalal Street is bracing for a sharp turnaround, with a pipeline of large issuers together expected to raise close to ₹33,000 crore in the second half of 2026. This cluster of offerings marks one of the most closely watched IPO windows in recent memory, led by heavyweight names spanning healthcare, quick commerce, and infrastructure.

Which Market Conditions Are Fueling Renewed IPO Confidence?

The renewed appetite stems from a combination of improving macro conditions and stronger domestic liquidity. Benchmark indices have found firmer footing after the volatility of the first half, mutual fund SIP inflows continue to provide a steady bid for equities, and expectations of a softer interest rate stance have improved risk appetite across investor categories. Anchor books for upcoming offers are also reportedly seeing stronger interest from long-only domestic institutions and global funds looking to add India exposure.

Mainboard vs SME: Where Is the Bigger Momentum?

Big-ticket mainboard names such as Manipal Health, Zepto, and Cube Highways account for the bulk of the expected ₹33,000-crore issuance, giving H2 2026 a distinctly large-cap flavour. That said, the SME segment is expected to remain active in terms of sheer number of issues, even though individual deal sizes there are far smaller. The contrast is straightforward: mainboard offerings will dominate the total money raised, while SME listings will continue to offer investors a higher volume of smaller, sector-diverse opportunities.

Manipal Health IPO: What Should Investors Know?

What Is Manipal Health's Business and Growth Story?

Manipal Health Enterprises is one of India's largest multi-specialty hospital chains, and its upcoming IPO is widely seen as a marquee event within the broader ₹33,000-crore pipeline for H2 2026. The company runs a wide network of hospitals across multiple states, catering to both tertiary and quaternary care segments, and has built a reputation around scale, specialty depth, and consistent bed-capacity expansion.

The hospital group's growth story has been built on steady occupancy improvement, a expanding footprint through both greenfield projects and acquisitions, and rising average revenue per occupied bed as case complexity increases. Healthcare as a sector has also benefited from resilient domestic demand, insurance penetration gradually rising, and medical tourism adding an incremental revenue stream, all factors likely to feature prominently in the company's IPO pitch to investors.

How Big Could the Manipal Health IPO Be?

While the exact issue size is yet to be finalised through regulatory filings, market participants expect the Manipal Health offering to be one of the largest hospital-sector listings India has seen, contributing meaningfully to the overall ₹33,000-crore H2 2026 target. A sizeable primary component alongside an offer-for-sale structure is generally expected for large private equity-backed healthcare issuers of this scale.

Valuation conversations around Manipal Health are still at an early stage, with analysts likely to benchmark it against listed hospital peers on metrics such as EV/EBITDA and revenue per bed. Grey-market premium activity typically only becomes meaningful closer to the actual bidding window, so investors tracking the Manipal Health IPO should watch for updated GMP trends, anchor investor allocation news, and subscription data on platforms like IPO Plus once the offer formally opens.

What Are Early Expectations on Valuation and GMP?

Zepto and Cube Highways IPOs: What's the Investor Outlook?

Why Is Zepto's IPO Generating So Much Buzz?

Zepto, one of India's fastest-growing quick-commerce platforms, is generating outsized attention because it represents one of the country's most closely tracked consumer-tech listings in years. The company's rapid expansion in ultra-fast grocery and daily essentials delivery, backed by aggressive dark-store rollout and a young, digitally native customer base, has made it a bellwether for how public markets will value India's new-age consumer internet businesses.

Investor interest in Zepto's IPO also reflects broader curiosity about the quick-commerce sector's path to profitability. Unlike earlier consumer-tech listings that faced scrutiny over sustained losses, Zepto's narrative will likely hinge on unit economics, order density, and how quickly operating leverage kicks in as the company scales toward its public listing.

What Makes Cube Highways an Attractive Infrastructure Bet?

Cube Highways offers a very different, more defensive investment case built around toll-road infrastructure assets that generate predictable, annuity-like cash flows. As an infrastructure platform with a portfolio of operating highway projects, Cube Highways appeals to investors seeking exposure to India's road infrastructure growth story without the volatility typically associated with consumption or technology-driven businesses.

Comparing the two, Zepto sits firmly in the higher-growth, higher-risk bracket typical of consumer internet IPOs, where valuation multiples depend heavily on future growth assumptions. Cube Highways, by contrast, is likely to be assessed more on yield, asset quality, and debt levels, making it a relatively lower-volatility addition to the H2 2026 IPO calendar. Together, the two issues give investors a genuine choice between growth-oriented and income-oriented primary market exposure within the same listing season.

How Do These Two IPOs Compare in Risk and Scale?

How Can Investors Prepare for the Upcoming IPO Wave?

How to Track Live Subscription and GMP Data Effectively?

Investors can prepare for the H2 2026 IPO wave by consistently monitoring live subscription figures and grey-market premium movement rather than relying on one-time news updates. Subscription data across retail, non-institutional, and qualified institutional buyer categories often shifts meaningfully in the final hours of bidding, making real-time tracking far more useful than static reports.

Grey-market premium should be treated as a directional sentiment indicator rather than a guaranteed listing-price outcome, since GMP levels can swing quickly based on broader market mood, anchor investor response, and last-minute demand from high-net-worth applicants. Cross-checking GMP trends against actual subscription strength gives a more balanced read on how an issue like Manipal Health, Zepto, or Cube Highways might perform on listing day.

What Should You Check Before Applying to an IPO?

Before applying to any IPO in this pipeline, investors should review the company's financial track record, revenue and margin trends, promoter and private equity shareholding pattern, and how the raised capital will actually be deployed. It is equally important to check the proportion of the offer structured as a fresh issue versus an offer-for-sale, since a heavy offer-for-sale component means existing shareholders are cashing out rather than the company raising fresh growth capital.

Other checkpoints worth a quick review include the lock-in period for anchor investors, litigation or regulatory disclosures in the prospectus, and how the issue is priced relative to listed peers in the same sector. These factors matter just as much as headline growth numbers when deciding whether an IPO deserves a place in your portfolio.

Where to Follow Real-Time Allotment and Listing Updates

Given the scale of the expected ₹33,000-crore issuance this half, staying updated through a dedicated tracking platform becomes essential rather than optional. IPO Plus offers live subscription numbers, grey-market premium tracking, allotment status checks, and broker reviews in one place, helping investors follow the Manipal Health, Zepto, Cube Highways, and other upcoming issues without having to piece together information from scattered sources.

Frequently Asked Questions

What is the total expected size of the H2 2026 IPO pipeline?

Market estimates put the expected IPO issuance for H2 2026 at around ₹33,000 crore, led by large mainboard names such as Manipal Health, Zepto, and Cube Highways.

Why was the Indian IPO market muted in H1 2026?

H1 2026 stayed muted due to global market volatility, cautious foreign institutional flows, interest rate uncertainty, and thinner grey-market premiums that discouraged aggressive new listings.

What sector does Manipal Health operate in?

Manipal Health Enterprises operates a large multi-specialty hospital network across India, offering tertiary and quaternary healthcare services.

Is Zepto's IPO expected to be a large listing?

Yes, Zepto's IPO is expected to be one of the most closely watched consumer-tech listings in India given its scale in the quick-commerce sector, though final issue size will depend on regulatory filings.

What kind of business is Cube Highways?

Cube Highways is an infrastructure platform focused on operating toll-road assets that generate steady, annuity-like cash flows, making it a relatively defensive IPO option.

How can I track grey-market premium for upcoming IPOs?

You can track live grey-market premium, subscription numbers, and allotment status for upcoming IPOs like Manipal Health, Zepto, and Cube Highways on platforms such as IPO Plus.

What should investors check before applying to a mainboard IPO?

Investors should review financial performance, promoter background, offer-for-sale versus fresh issue proportion, valuation compared to listed peers, and use of IPO proceeds before applying.

Related articles

Frequently asked questions

What is the total expected size of the H2 2026 IPO pipeline?
Market estimates put the expected IPO issuance for H2 2026 at around ₹33,000 crore, led by large mainboard names such as Manipal Health, Zepto, and Cube Highways.
Why was the Indian IPO market muted in H1 2026?
H1 2026 stayed muted due to global market volatility, cautious foreign institutional flows, interest rate uncertainty, and thinner grey-market premiums that discouraged aggressive new listings.
What sector does Manipal Health operate in?
Manipal Health Enterprises operates a large multi-specialty hospital network across India, offering tertiary and quaternary healthcare services.
Is Zepto's IPO expected to be a large listing?
Yes, Zepto's IPO is expected to be one of the most closely watched consumer-tech listings in India given its scale in the quick-commerce sector, though final issue size will depend on regulatory filings.
What kind of business is Cube Highways?
Cube Highways is an infrastructure platform focused on operating toll-road assets that generate steady, annuity-like cash flows, making it a relatively defensive IPO option.
How can I track grey-market premium for upcoming IPOs?
You can track live grey-market premium, subscription numbers, and allotment status for upcoming IPOs like Manipal Health, Zepto, and Cube Highways on platforms such as IPO Plus.
What should investors check before applying to a mainboard IPO?
Investors should review financial performance, promoter background, offer-for-sale versus fresh issue proportion, valuation compared to listed peers, and use of IPO proceeds before applying.
Telegram App